Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry

Detalhes bibliográficos
Autor(a) principal: Kotseva, K
Data de Publicação: 2019
Outros Autores: De Backer, G, De Bacquer, D, Rydén, L, Hoes, A, Grobbee, D, Maggioni, A, Marques-Vidal, P, Jennings, C, Abreu, A, Aguiar, C, Badariene, J, Bruthans, J, Castro Conde, A, Cifkova, R, Crowley, J, Davletov, K, Deckers, J, De Smedt, D, De Sutter, J, Dilic, M, Dolzhenko, M, Dzerve, V, Erglis, A, Fras, Z, Gaita, D, Gotcheva, N, Heuschmann, P, Hasan-Ali, H, Jankowski, P, Lalic, N, Lehto, S, Lovic, D, Mancas, S, Mellbin, L, Milicic, D, Mirrakhimov, E, Oganov, R, Pogosova, N, Reiner, Z, Stöerk, S, Tokgözoğlu, L, Tsioufis, C, Vulic, D, Wood, D
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4474
Resumo: Aims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. Conclusion: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
id RCAP_e5830d319800ae5113fd03968bbe507c
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4474
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V RegistryHSM CARAgedFemaleMaleMiddle AgedHumansCardiovascular Agents / therapeutic use*Cardiovascular Diseases / diagnosisCardiovascular Diseases / epidemiologyCardiovascular Diseases / physiopathologyCardiovascular Diseases / prevention & control*Cross-Sectional StudiesDiet / adverse effectsEurope / epidemiologyHealth Care SurveysHealth StatusHealthy Lifestyle*Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*Life Style*Patient ComplianceProtective FactorsRegistriesRisk AssessmentRisk Reduction Behavior*Risk FactorsSecondary PreventionSedentary BehaviorSmoking / adverse effectsSmoking / epidemiologyTreatment OutcomeAims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. Conclusion: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.SageRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEKotseva, KDe Backer, GDe Bacquer, DRydén, LHoes, AGrobbee, DMaggioni, AMarques-Vidal, PJennings, CAbreu, AAguiar, CBadariene, JBruthans, JCastro Conde, ACifkova, RCrowley, JDavletov, KDeckers, JDe Smedt, DDe Sutter, JDilic, MDolzhenko, MDzerve, VErglis, AFras, ZGaita, DGotcheva, NHeuschmann, PHasan-Ali, HJankowski, PLalic, NLehto, SLovic, DMancas, SMellbin, LMilicic, DMirrakhimov, EOganov, RPogosova, NReiner, ZStöerk, STokgözoğlu, LTsioufis, CVulic, DWood, D2023-04-06T11:58:34Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4474engEur J Prev Cardiol . 2019;26(8):824-835.10.1177/2047487318825350info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-04-09T05:56:07Zoai:repositorio.chlc.min-saude.pt:10400.17/4474Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:49:04.979852Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
title Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
spellingShingle Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
Kotseva, K
HSM CAR
Aged
Female
Male
Middle Aged
Humans
Cardiovascular Agents / therapeutic use*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / prevention & control*
Cross-Sectional Studies
Diet / adverse effects
Europe / epidemiology
Health Care Surveys
Health Status
Healthy Lifestyle*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Life Style*
Patient Compliance
Protective Factors
Registries
Risk Assessment
Risk Reduction Behavior*
Risk Factors
Secondary Prevention
Sedentary Behavior
Smoking / adverse effects
Smoking / epidemiology
Treatment Outcome
title_short Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
title_full Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
title_fullStr Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
title_full_unstemmed Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
title_sort Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry
author Kotseva, K
author_facet Kotseva, K
De Backer, G
De Bacquer, D
Rydén, L
Hoes, A
Grobbee, D
Maggioni, A
Marques-Vidal, P
Jennings, C
Abreu, A
Aguiar, C
Badariene, J
Bruthans, J
Castro Conde, A
Cifkova, R
Crowley, J
Davletov, K
Deckers, J
De Smedt, D
De Sutter, J
Dilic, M
Dolzhenko, M
Dzerve, V
Erglis, A
Fras, Z
Gaita, D
Gotcheva, N
Heuschmann, P
Hasan-Ali, H
Jankowski, P
Lalic, N
Lehto, S
Lovic, D
Mancas, S
Mellbin, L
Milicic, D
Mirrakhimov, E
Oganov, R
Pogosova, N
Reiner, Z
Stöerk, S
Tokgözoğlu, L
Tsioufis, C
Vulic, D
Wood, D
author_role author
author2 De Backer, G
De Bacquer, D
Rydén, L
Hoes, A
Grobbee, D
Maggioni, A
Marques-Vidal, P
Jennings, C
Abreu, A
Aguiar, C
Badariene, J
Bruthans, J
Castro Conde, A
Cifkova, R
Crowley, J
Davletov, K
Deckers, J
De Smedt, D
De Sutter, J
Dilic, M
Dolzhenko, M
Dzerve, V
Erglis, A
Fras, Z
Gaita, D
Gotcheva, N
Heuschmann, P
Hasan-Ali, H
Jankowski, P
Lalic, N
Lehto, S
Lovic, D
Mancas, S
Mellbin, L
Milicic, D
Mirrakhimov, E
Oganov, R
Pogosova, N
Reiner, Z
Stöerk, S
Tokgözoğlu, L
Tsioufis, C
Vulic, D
Wood, D
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Kotseva, K
De Backer, G
De Bacquer, D
Rydén, L
Hoes, A
Grobbee, D
Maggioni, A
Marques-Vidal, P
Jennings, C
Abreu, A
Aguiar, C
Badariene, J
Bruthans, J
Castro Conde, A
Cifkova, R
Crowley, J
Davletov, K
Deckers, J
De Smedt, D
De Sutter, J
Dilic, M
Dolzhenko, M
Dzerve, V
Erglis, A
Fras, Z
Gaita, D
Gotcheva, N
Heuschmann, P
Hasan-Ali, H
Jankowski, P
Lalic, N
Lehto, S
Lovic, D
Mancas, S
Mellbin, L
Milicic, D
Mirrakhimov, E
Oganov, R
Pogosova, N
Reiner, Z
Stöerk, S
Tokgözoğlu, L
Tsioufis, C
Vulic, D
Wood, D
dc.subject.por.fl_str_mv HSM CAR
Aged
Female
Male
Middle Aged
Humans
Cardiovascular Agents / therapeutic use*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / prevention & control*
Cross-Sectional Studies
Diet / adverse effects
Europe / epidemiology
Health Care Surveys
Health Status
Healthy Lifestyle*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Life Style*
Patient Compliance
Protective Factors
Registries
Risk Assessment
Risk Reduction Behavior*
Risk Factors
Secondary Prevention
Sedentary Behavior
Smoking / adverse effects
Smoking / epidemiology
Treatment Outcome
topic HSM CAR
Aged
Female
Male
Middle Aged
Humans
Cardiovascular Agents / therapeutic use*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / prevention & control*
Cross-Sectional Studies
Diet / adverse effects
Europe / epidemiology
Health Care Surveys
Health Status
Healthy Lifestyle*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Life Style*
Patient Compliance
Protective Factors
Registries
Risk Assessment
Risk Reduction Behavior*
Risk Factors
Secondary Prevention
Sedentary Behavior
Smoking / adverse effects
Smoking / epidemiology
Treatment Outcome
description Aims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. Conclusion: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
2023-04-06T11:58:34Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4474
url http://hdl.handle.net/10400.17/4474
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Prev Cardiol . 2019;26(8):824-835.
10.1177/2047487318825350
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sage
publisher.none.fl_str_mv Sage
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131572114292736